Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Eli Lilly and Co's share price for the quarter that ended in Dec. 2023 was R$93.42. Eli Lilly and Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 28,481 Mil. Therefore, Eli Lilly and Co's market cap for the quarter that ended in Dec. 2023 was R$2,660,732 Mil.
Eli Lilly and Co's quarterly market cap
increased
from Jun. 2023 (R$2,135,895 Mil) to Sep. 2023 (R$2,557,993 Mil) and
increased
from Sep. 2023 (R$2,557,993 Mil) to Dec. 2023 (R$2,660,732 Mil).
Eli Lilly and Co's annual market cap
increased
from Dec. 2021 (R$1,464,505 Mil) to Dec. 2022 (R$1,842,025 Mil) and
increased
from Dec. 2022 (R$1,842,025 Mil) to Dec. 2023 (R$2,660,732 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Eli Lilly and Co's Enterprise Value for Today is R$3,714,773 Mil.
Eli Lilly and Co Market Cap Historical Data
The historical data trend for Eli Lilly and Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eli Lilly and Co's Market Cap
For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eli Lilly and Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Eli Lilly and Co's Market Cap falls into.
Eli Lilly and Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Eli Lilly and Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eli Lilly and Co (BSP:LILY34) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Eli Lilly and Co Market Cap Related Terms
Thank you for viewing the detailed overview of Eli Lilly and Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Eli Lilly and Co (BSP:LILY34) Business Description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:LILY34 has been successfully added to your 